Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03793062 · ClinicalTrials.gov registry record
Genetic and Epigenetic Basis of Chronic Wounds
A clinical trial of Chronic Wounds, sponsored by University of Pittsburgh.
- Recruiting
- Registry status
- 256
- Enrollment target
- 1
- Study location
NCT03793062: Recruiting study of Chronic Wounds, sponsored by University of Pittsburgh.
NCT03793062 is a study of Chronic Wounds that is actively recruiting participants, run by University of Pittsburgh. The registered enrollment target is 256 participants, above the 121-participant average among 4 other Chronic Wounds trials with a reported enrollment target (112% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03793062, a study of Chronic Wounds, is actively recruiting participants, sponsored by University of Pittsburgh.
- RECRUITING
- Registry status
- 256 participants
- Enrollment target
- 1
- Study location
Study Summary
This pilot study is designed for chronic wounds that fail to heal in a timely manner carry specific genetic signatures. These genetic signatures will be studied using debrided wound tissue that is removed by the wound care provider as part of standard of care. The reference genomic signature will be evaluated by obtaining blood samples and will be compared with wound debrided tissue genomic signature to understand wound specific genomic changes.
Primary Outcome
The wound area (digital planimetry at d0/ 16 week) will classify wounds as heal-high (final 16 week size \<40% of initial visit, d0) or heal-low (\>60% of initial d0).
Conditions Studied
Interventions
- OTHER No Interventions
Study Locations (1)
Pennsylvania
- UPMC Wound Care Centers - Pittsburgh
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 256 participants |
| Start Date | 2018-12-04 |
| Est. Completion | 2028-12-31 |
What NCT03793062 shows while recruiting
NCT03793062 is an observational study that tracks outcomes without assigning an intervention. The registered 256 participants enrollment target is mid-sized for trials with a published cap, above the 121-participant average among 4 other Chronic Wounds trials with a reported enrollment target (112% higher).
The record links to 1 condition, with Chronic Wounds appearing as the primary indexed condition, and to 1 intervention - of which No Interventions is the first listed.
NCT03793062 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT03793062 about?
NCT03793062 is a clinical study titled "Genetic and Epigenetic Basis of Chronic Wounds". This pilot study is designed for chronic wounds that fail to heal in a timely manner carry specific genetic signatures. These genetic signatures will be studied using debrided wound tissue that is removed by the wound care provider as part of standard of care. The reference genomic signature will be...
What is the current status of trial NCT03793062?
This trial is currently recruiting. The enrollment target is 256 participants. The study started on 2018-12-04. Estimated completion is 2028-12-31.
What conditions does trial NCT03793062 study?
This clinical trial studies the following conditions: Chronic Wounds.
What interventions are being tested in trial NCT03793062?
The interventions under investigation include: No Interventions (OTHER).
Who is sponsoring clinical trial NCT03793062?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03793062 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Chronic Wounds
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Study of Miro3D Wound Matrix for Healing Wounds and Ulcers in Outpatient Care
RECRUITING · NA
-
Diabetic Foot Ulcer (DFU) Biofilm Infection and Recurrence
RECRUITING
-
Retrospective, Multi-center Real-world Study of StimLabs Human Placental Membrane Tissue to Treat Hard-to-Heal Wounds
ACTIVE NOT RECRUITING
-
Clinical Utility of a New Silver Gel for Use on Chronic Wounds
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02464696 · 256 participants · NA
Non-invasive Ventilation in Reducing the Need for Intubation in Patients With Cancer and Respiratory Failure
- NCT04322318 · 256 participants · Phase 2
A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT
- NCT04468360 · 256 participants · Phase 2
Facilitation of Extinction Retention and Reconsolidation Blockade in PTSD
- NCT04851613 · 256 participants · Phase 3
Study to Evaluate Efficacy & Safety of Afuresertib Plus Fulvestrant in Patients With Locally Advanced or Metastatic HR+/HER2- Breast Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI